About the Journal
INNOVAPATHTM: Journal of Translational Medicine & Biotechnology is a premier scientific journal of the INNOVACORE Center for Research & Biotechnology and CorePath Laboratories. Our mission is to bridge the gap between scientific discovery and clinical application by publishing cutting-edge research in translational medicine, pathology, biotechnology, precision medicine, clinical research and innovations in healthcare. We aim to accelerate the development of innovative diagnostics, therapeutics, and biomedical technologies by fostering collaboration between researchers, clinicians, and industry leaders.
INNOVAPATHTM accepts a wide range of publications for peer-review including full manuscripts, case reports, review articles, opinions, medical masterclass, and commentaries. Our focus encompasses basic, translational and clinical research, clinical medicine, pathology, biotechnology, medical education, innovation, and public health. We are dedicated to advancing knowledge and promoting impactful research that transforms healthcare and enhances patient outcomes. Join us in our mission to lead the future of medical and biotechnological innovation.
INNOVAPATH™️: Journal of Translational Medicine & Biotechnology is a fully open-access, online-only journal published and financially supported by the INNOVACORE™️ Center for Research & Biotechnology and CorePath Laboratories (San Antonio, Texas, USA).
The journal does not charge any submission, review, or publication fees (no APCs). All articles are made freely available at the time of publication under a CC BY 4.0 open-access license, and authors retain copyright.
Operational costs, including editorial management, peer-review administration, copyediting, typesetting, DOI registration (Crossref), online hosting (OJS), indexing, and archiving, are covered through the sponsoring institutions’ internal budgets and in-kind staff support rather than through author fees or subscriptions.
The journal follows a non-profit, institutionally subsidized model aimed at maximizing dissemination and impact of translational medicine and biotechnology research, particularly in low- and middle-income settings. This model is designed to be sustainable through ongoing institutional commitment from INNOVACORE and CorePath, with no dependence on commercial advertising or paywalled content.
Publication in the journal is free for all submissions; no article processing or publication charges apply.
Publication Schedule:
The journal will be published on a quarterly schedule, four times a year.